SGCB and pulmonary arterial hypertension: Accordingly, substantial experimental data have suggested the impaired sGC activity in the pathogenesis of PAH (Schermuly et al., 2008; Ghofrani and Grimminger, 2009; Stasch et al., 2011; Dasgupta et al., 2015).